Validation of a miRNA Panel to Optimize Treatment Response in Patients With Metastatic Pancreatic Cancer (mirPANC 2)

Abroad (travel likely)Recruiting

Conditions

Pancreatic Cancer · Metastasis · Epigenetic

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

A Beneficência Portuguesa de São Paulo, São Paulo, São Paulo, Brazil
Contact: Study coordinator (Bianca Verboski) · bianca.verboski@bp.org.br · +551135055031
Contact: Study coordinator (Camila Farias) · camila.farias@bp.org.br · +551135054680

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer

Pancreatic Cancer, Adult

Abroad (travel likely)RecruitingPHASE3

Tianjin, China

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

Metastatic Colorectal Cancer · Metastatic Pancreatic Cancer · Metastatic Ovarian Cancer

Abroad (travel likely)RecruitingPHASE2

Bethesda, United States

EXoPERT EMERALD Clinical Study

Breast Cancer · Colon Cancer · Pancreatic Cancer

Abroad (travel likely)Recruiting

Long Beach, United States · Los Angeles, United States

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma · Stage II Pancreatic Cancer AJCC v8 · Stage III Pancreatic Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE3

Gilbert, United States · Gilbert, United States